T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Park National Corp
PRK
$3.72B
| $2.21M | ﹤0.01% |
15,501
+33
| +0.2% | +$4.44K |
|
1502
CoreCivic
CXW
$3.32B
| $2.21M | ﹤0.01% |
169,863
-44,873
| -21% | -$655K |
|
1503
DXC Technology
DXC
$1.79B
| $2.2M | ﹤0.01% |
115,376
+776
| +0.7% | +$14.6K |
|
1504
iShares Russell 1000 Value ETF
IWD
$84.3B
| $2.2M | ﹤0.01% |
12,626
-1,507
| -11% | -$263K |
|
1505
Cactus
WHD
$5.78B
| $2.2M | ﹤0.01% |
41,624
+2,126
| +5% | +$108K |
|
1506
Axsome Therapeutics
AXSM
$11.2B
| $2.19M | ﹤0.01% |
27,175
+1,901
| +8% | +$141K |
|
|
ALTM
1507
DELISTED
Arcadium Lithium plc
ALTM
| $2.18M | ﹤0.01% |
649,643
+70,948
| +12% | +$296K |
|
|
CERE
1508
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $2.18M | ﹤0.01% |
53,401
-281,956
| -84% | -$11.7M |
|
|
PENG
1509
Penguin Solutions Inc
PENG
$3.12B
| $2.18M | ﹤0.01% |
95,135
+13,161
| +16% | +$274K |
|
1510
AutoNation
AN
$6.9B
| $2.17M | ﹤0.01% |
13,639
-103
| -0.7% | -$16.8K |
|
1511
Pennant Group
PNTG
$1.34B
| $2.17M | ﹤0.01% |
93,598
-36,503
| -28% | -$800K |
|
1512
Chemours
CC
$2.29B
| $2.17M | ﹤0.01% |
96,095
+4,750
| +5% | +$124K |
|
1513
WD-40
WDFC
$3.09B
| $2.17M | ﹤0.01% |
9,874
+421
| +4% | +$97.3K |
|
|
CVSA
1514
Covista Inc
CVSA
$4.36B
| $2.16M | ﹤0.01% |
31,714
+75
| +0.2% | +$4.4K |
|
1515
Northern Oil and Gas
NOG
$2.61B
| $2.16M | ﹤0.01% |
58,091
+6,371
| +12% | +$256K |
|
|
SWI
1516
DELISTED
SolarWinds Corporation Common Stock
SWI
| $2.16M | ﹤0.01% |
179,048
+146,302
| +447% | +$1.69M |
|
1517
Unifirst Corp
UNF
$5.24B
| $2.14M | ﹤0.01% |
12,498
+168
| +1% | +$27.1K |
|
1518
Westamerica Bancorp
WABC
$1.38B
| $2.13M | ﹤0.01% |
43,895
-7,809
| -15% | -$373K |
|
1519
RXO
RXO
$3.85B
| $2.12M | ﹤0.01% |
81,153
+5,351
| +7% | +$111K |
|
1520
Bank of Hawaii
BOH
$3.13B
| $2.11M | ﹤0.01% |
36,925
+4,044
| +12% | +$235K |
|
1521
ABM Industries
ABM
$2.84B
| $2.11M | ﹤0.01% |
41,738
+2,021
| +5% | +$94.3K |
|
1522
FIVE9
FIVN
$2.53B
| $2.11M | ﹤0.01% |
47,838
+3,011
| +7% | +$156K |
|
1523
Metropolitan Bank Holding Corp
MCB
$1.17B
| $2.11M | ﹤0.01% |
50,094
+1,401
| +3% | +$56K |
|
1524
V2X
VVX
$2.55B
| $2.11M | ﹤0.01% |
43,876
+22,289
| +103% | +$1.06M |
|
1525
Silicon Laboratories
SLAB
$7.3B
| $2.1M | ﹤0.01% |
19,001
+1,238
| +7% | +$153K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.